Accipiter Biosciences
PrivateLast Round
Seed
Jul 28, 2026
Total Funding Raised
$26.85M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Accipiter Biosciences is a biotechnology company that develops de novo multifunctional biologics to treat complex diseases using its computational platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accipiter Biosciences Comparables
Compare Accipiter Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Archon Biosciences | 87% | |
| AI Proteins | 85% | |
| Ability Biotherapeutics | 83% |
Accipiter Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 28, 2026 | ||||
| Seed | Nov 6, 2025 | ||||
| Seed | Nov 6, 2025 | ||||
| Pre Seed | May 2, 2023 | ||||
| Seed | Mar 27, 2023 |
Key People
Founding team and executive leadership
Accipiter Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Argonautic Ventures | Seed |
| Pack Ventures | Seed |
| Washington Research Foundation Capital | Seed |
| Alexandria Venture Investments | Seed |
| Cercano Management | Seed |
| Argonautic Ventures | Seed |
| Flying Fish Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 196% MoM.
- Jul 28, 2026
$10.5M raised in Seed Round.
Recent news
Latest coverage and updates
- is_developingAug 10, 2026
Accipiter Bio is developing lead oncology program on Aug 10th '26.
- receives_financingAug 4, 2026
Accipiter Bio received financing of $10.5M in Seed on Aug 4th '26.
- receives_financingAug 2, 2026
Accipiter Bio received financing of $10.5M in Series A on Mar 1st '26.
- receives_financingAug 1, 2026
Accipiter Bio received financing of $10.5M in Seed 1 on Jan 1st '24.
- partners_withJul 31, 2026
Accipiter Bio partners with Pfizer Inc.
Accipiter Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Accipiter Biosciences's valuation, stock price, and market status.
Is Accipiter Biosciences a public or private company?
Accipiter Biosciences is a private company.
What is the current stock price of Accipiter Biosciences?
Accipiter Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Accipiter Biosciences worth (valuation)?
Valuation information for Accipiter Biosciences is not publicly available.
Can I buy Accipiter Biosciences stock?
Accipiter Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Accipiter Biosciences's last funding round?
Accipiter Biosciences's most recent funding round was Seed on November 6, 2025.
Who are the main investors in Accipiter Biosciences?
Key investors in Accipiter Biosciences include Flying Fish Partners.
Will Accipiter Biosciences IPO soon?
No public IPO plans have been announced for Accipiter Biosciences.
How can I track Accipiter Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Accipiter Biosciences's secondary market activity and sign up for updates.